Grants per year
Personal profile
Training Experience
| 2009 | Residency, Rush University Medical Center |
| 2012 | Fellowship, Rush University Medical Center |
Education/Academic qualification
MS, Clinical Research, Rush University
… → 2012
MD, Medicine, Western University
… → 2006
Fingerprint
Dive into the research topics where Reem Karmali is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Prot #GO44145: A Phase III, Multicenter, Randomized, Open-Label Study Comparing The Efficacy and Safety of Glofitamab (RO7082859) in Combination with Polatuzumab Vedotin Plus Rituximab, Cyclophospamide, Doxorubicin, and Prednisone (POLA-R-CHP) Versus POLA
Karmali, R. (PD/PI)
7/18/24 → 5/31/29
Project: Research project
-
Prot #CRG‐022‐101: An Open‐label, Multicenter Phase 2 Study Evaluating the Efficacy and Safety of CRG‐022, a CD22‐Directed Autologous Chimeric Antigen Receptor (CAR) T‐cell Therapy in Patients With Relapsed/Refractory Large B‐Cell Lymphoma After CD19‐Dire
Karmali, R. (PD/PI)
Novella Clinical, LLC, CARGO Therapeutics, Inc.
5/24/24 → 5/24/27
Project: Research project
-
Prot #KT-US-472-0141: Expanded Access Study for the Treatment of Patients with Commercially Out-of-Specification Brexucabtagene Autoleuce
Karmali, R. (PD/PI)
ICON Clinical Research Limited, Kite Pharma, Inc.
1/22/24 → 1/22/27
Project: Research project
-
Anti-CD19 chimeric antigen receptor T-cell therapy in older patients with relapsed or refractory large B-cell lymphoma: A multicenter study
Tun, A. M., Patel, R. D., St-Pierre, F., Ouchveridze, E., Niu, A., Thordardottir, T., Obasi, J., Rosenthal, A., Pophali, P. A., Fenske, T. S., Karmali, R., Ahmed, S. & Johnston, P. B., Sep 2024, In: American Journal of Hematology. 99, 9, p. 1712-1720 9 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
A phase 1-2 trial of DA-EPOCH-R plus ixazomib for MYC-aberrant lymphoid malignancies: the DACIPHOR regimen
Karmali, R., Galvez, C., Hamadani, M., Gordon, L., Winter, J. N., Ma, S., Nelson, V., Fenske, T. S., Shah, N. N., Jagadeesh, D., Klein, A., Helenowski, I., Chen, R., Mi, X., Petrich, A., Evens, A. M. & Pro, B., Apr 9 2024, In: Blood Advances. 8, 7, p. 1612-1620 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
ASCT2-Targeting Antibody-Drug Conjugate MEDI7247 in Adult Patients with Relapsed/Refractory Hematological Malignancies: A First-in-Human, Phase 1 Study
Maris, M., Salles, G., Kim, W. S., Kim, T. M., Lyons, R. M., Arellano, M., Karmali, R., Schiller, G., Cull, E., Abboud, C. N., Batlevi, C., Kagiampakis, I., Rebelatto, M. C., Lee, Y., Kirby, L. C., Wang, F., Bothos, J., Townsley, D. M., Fathi, A. T. & Ribrag, V., May 2024, In: Targeted Oncology. 19, 3, p. 321-332 12 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Dosing of 7 + 3 induction chemotherapy in a patient with acute myeloid leukemia (AML) and morbid obesity
Franco, S., Khan, T., Dinner, S., Karmali, R. & Melody, M., Aug 2024, In: Journal of Oncology Pharmacy Practice. 30, 5, p. 945-949 5 p.Research output: Contribution to journal › Article › peer-review
-
Harnessing the Systemic Biology of Functional Decline and Cachexia to Inform more Holistic Therapies for Incurable Cancers
Willbanks, A., Seals, M., Karmali, R. & Roy, I., Jan 2024, In: Cancers. 16, 2, 360.Research output: Contribution to journal › Review article › peer-review
Open Access
Datasets
-
Impact of early relapse within 24 months after first-line systemic therapy (POD24) on outcomes in patients with marginal zone lymphoma: A US multisite study
Epperla, N. (Creator), Welkie, R. L. (Creator), Torka, P. (Creator), Shouse, G. (Creator), Karmali, R. (Creator), Shea, L. (Creator), Anampa-Guzmán, A. (Creator), Oh, T. S. (Creator), Reaves, H. (Creator), Tavakkoli, M. (Creator), Lindsey, K. (Creator), Greenwell, I. B. (Creator), Hansinger, E. (Creator), Thomas, C. (Creator), Chowdhury, S. M. (Creator), Annunzio, K. (Creator), Christian, B. (Creator), Barta, S. K. (Creator), Geethakumari, P. R. (Creator), Bartlett, N. L. (Creator), Herrera, A. F. (Creator), Grover, N. S. (Creator), Olszewski, A. J. (Creator), Shea, L. (Creator), Oh, T. S. (Creator), Reaves, H. (Creator), Tavakkoli, M. (Creator), Hansinger, E. (Creator), Thomas, C. (Creator), Bartlett, N. L. (Creator) & Olszewski, A. J. (Creator), figshare, 2023
DOI: 10.6084/m9.figshare.c.6638327, https://springernature.figshare.com/collections/Impact_of_early_relapse_within_24_months_after_first-line_systemic_therapy_POD24_on_outcomes_in_patients_with_marginal_zone_lymphoma_A_US_multisite_study/6638327
Dataset